Citadel Advisors’s Virtus LifeSci Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-34,631
| Closed | -$968K | – | 5975 |
|
|
2024
Q3 | $968K | Sell |
34,631
-5,469
| -14% | -$153K | ﹤0.01% | 3144 |
|
|
2024
Q2 | $1.01M | Buy |
+40,100
| New | +$1.01M | ﹤0.01% | 3023 |
|
|
2024
Q1 | – | Sell |
-37,327
| Closed | -$913K | – | 6109 |
|
|
2023
Q4 | $913K | Buy |
37,327
+1,815
| +5% | +$44.4K | ﹤0.01% | 3125 |
|
|
2023
Q3 | $697K | Buy |
35,512
+1,824
| +5% | +$35.8K | ﹤0.01% | 3412 |
|
|
2023
Q2 | $807K | Buy |
33,688
+925
| +3% | +$22.2K | ﹤0.01% | 3188 |
|
|
2023
Q1 | $718K | Buy |
+32,763
| New | +$718K | ﹤0.01% | 3502 |
|
|
2021
Q1 | – | Sell |
-12,801
| Closed | -$635K | – | 6252 |
|
|
2020
Q4 | $635K | Buy |
12,801
+2,083
| +19% | +$103K | ﹤0.01% | 3669 |
|
|
2020
Q3 | $418K | Buy |
+10,718
| New | +$418K | ﹤0.01% | 3626 |
|
|
2019
Q4 | – | Sell |
-13,951
| Closed | -$332K | – | 4619 |
|
|
2019
Q3 | $332K | Buy |
13,951
+5,834
| +72% | +$139K | ﹤0.01% | 3777 |
|
|
2019
Q2 | $234K | Buy |
+8,117
| New | +$234K | ﹤0.01% | 4025 |
|
|
2018
Q4 | – | Sell |
-18,447
| Closed | -$638K | – | 4493 |
|
|
2018
Q3 | $638K | Buy |
+18,447
| New | +$638K | ﹤0.01% | 3017 |
|
|
2017
Q1 | – | Sell |
-23,166
| Closed | -$426K | – | 3649 |
|
|
2016
Q4 | $426K | Buy |
+23,166
| New | +$426K | ﹤0.01% | 2590 |
|
|
2016
Q3 | – | Sell |
-16,139
| Closed | -$291K | – | 3565 |
|
|
2016
Q2 | $291K | Buy |
+16,139
| New | +$291K | ﹤0.01% | 2561 |
|
|
2016
Q1 | – | Sell |
-32,531
| Closed | -$945K | – | 3335 |
|
|
2015
Q4 | $945K | Buy |
32,531
+19,928
| +158% | +$579K | ﹤0.01% | 2010 |
|
|
2015
Q3 | $333K | Buy |
+12,603
| New | +$333K | ﹤0.01% | 2870 |
|